Catherine Youdan is a partner who practises securities law at Blake, Cassels & Graydon LLP, with a focus on corporate finance and mergers & acquisitions. She has acted on behalf of issuers and underwriters in connection with public and private financings (including many Canada/US cross-border financings) and on behalf of purchasers (including private equity sponsors) and targets in public company acquisitions and purchasers and vendors in private company asset and share purchase transactions. Catherine has experience in industries such as consumer/retail, real estate, financial services, and mining. She also provides ongoing advice to public issuers with respect to corporate governance requirements, continuous disclosure obligations, and stock exchange matters. Prior to joining Blakes, Catherine practised at another prominent Toronto law firm. She also spent one year practising at a leading US law firm in New York as part of the foreign lawyer visiting program.
On February 9, 2017, Sprott Resource Corp. (“SRC”) and Adriana Resources Inc. (now re-named Sprott Resource Holdings Inc.) (the “Company”) completed a business combination by way of a court approved plan of arrangement under the Canada Business Corporations Act (the “Arrangement”).
On April 21, 2015, Concordia Healthcare Corp. (Concordia), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, acquired 18 products from Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l (collectively, Covis). The purchase price of US$1.2 billion was paid in cash at closing.
On October 3, 2006 Georgia Gulf Corporation of Atlanta, Georgia completed its previously announced acquisition of Royal Group Technologies Limited of Toronto in an all cash and assumed debt transaction, which values Royal Group at approximately $1.7 billion. The closing of the acquisition brings to an end a 16-month public sale process for Royal Group that began in May 2005 ...